Patent ID: 9260430
Filing Date: 2016-02-16
CPC Classification: A61K,C07D,Y02A

Claim Text:
1. A method of preventing or treating an injury resulting from exposure to a biological warfare agent comprising administering to a subject in need thereof an effective amount of a TRPA1 antagonist or a pharmaceutically acceptable salt thereof, wherein the biological warfare agent is selected from the group consisting of Bacillus anthracis (anthrax), Burkholderia mallei (glanders), Burkholderia psuedomallei (melioidosis), Clostridium botulinum toxin (botulism), Ebola virus, Francisella tularensis (tularemia), Marburg virus, Vibrio cholera (cholera), alphaviruses, Venezuelan equine encephalitis virus, eastern equine encephalitis virus, western equine encephalitis virus, filoviruses, arenaviruses, Lassa virus, Machupo virus and Yersinia pestis (plague).